Background and objectives: Subarachnoid hemorrhage (SAH) during pregnancy is a rare event, and about half the cases are due to arteriovenous malformations (AVM). The authors describe the anesthetic approach of a 39 week pregnant patient scheduled for cesarean section, with a history of SAH due to AVM at 22 week gestation. Case report: 39 week pregnant patient, healthy prior to pregnancy, with a history of SAH at 22 week gestation, manifested by headache, vomiting, and dizziness without loss of consciousness or other defi cits on admission to the emergency room. Magnetic resonance imaging (MRI) revealed a left frontal AVM. After a short hospital stay for stabilization and diagnosis, the fi nal medical decision was to maintain the pregnancy and a multidisciplinary follow-up by neurosurgery and high-risk obstetric consultation. An elective cesarean section was performed at 39 weeks under epidural anesthesia. During the intraoperative period, an episode of hypotension rapidly reversed with phenylephrine occurred. The newborn Apgar score was 10/10. An epidural catheter was used for postoperative analgesia, also uneventful. Conclusions: There are very few published cases of anesthetic approach for pregnant women with symptomatic AVM. All decisions made by the multidisciplinary team, from choosing to continue the pregnancy to the ideal time for AVM intervention and type of anesthesia and analgesia, were weighted according to the risk of brain damage. Regarding the anesthetic procedure, the authors emphasize the need for hemodynamic stability.
Introduction
Brain arteriovenous malformations (AVM) typically appear between the age of 25 and 45 years, with a peak incidence in the 4 th decade [1] [2] [3] [4] . Despite its congenital origin, only 18-20% are diagnosed in childhood 5 . AVM may present itself as intracranial hemorrhage (30-86%), seizures (8-46%) and/or focal neurological defi cits (4-23%), headache (up to 15%), hydrocephalus and, rarely, congestive heart failure 4, 6 . Incidence of subarachnoid hemorrhage (SAH) during pregnancy is estimated at about 1-10 per 100,000 pregnant women 7 . AVM are responsible for about 50% of SAH in pregnant women and the 3 rd cause of non-obstetric maternal morbidity 8 . However, it is known that even without rupture, AVM may cause brain damage by brain "steal phenomenon" or by decreasing the cerebral perfusion 6 . There is controversy about the infl uence of pregnancy on natural history of AVM; however, the risk of fi rst rupture during pregnancy is 3.5%, which is similar to non-pregnant woman 9 . In these cases, treatment during pregnancy is based on neurological factors rather than obstetric indications 3 . The authors describe the anesthetic strategy for a pregnant woman scheduled for elective cesarean section, with a history of SAH due to AVM rupture at 22 weeks of gestation. The approach, performed by a multidisciplinary team: (obstetrician, anesthesiologist, neurologist, and neonatologist) implied the following: clarifi cation of the diagnosis and clinical stabilization of the baseline condition, decision to continue the pregnancy, follow-up during the remainder of pregnancy, safety of anesthesia and delivery, and AVM embolization in the postpartum period.
Case Report
Female patient, 30 years old, 39 weeks of gestation, obese (BMI = 31 kg.m -2 ), nillipara, admitted for elective cesarean section. Patient received follow-up from the 22 nd gestational week in multidisciplinary consultation by SAH in the context of AVM.
At 22 weeks of gestation, the patient was admitted to the Emergency Service with acute occipital headache and persistent dizziness with 10 hours of evolution, without focal neurologic defi cits or loss of consciousness. After fetal well-being was confi rmed by obstetrics, the patient was admitted to the neurosurgery department for diagnostic and clinical stabilization.
Cranial Computed Axial Tomography (CAT-scan) showed minor bleeding of the right caudate nucleus and the fourth ventricle.
Cerebral magnetic resonance imaging (MRI) revealed cortical-ventricular AVM on left frontal region, with about 4 cm in diameter, with nutrition of the anterior cerebral artery and drainage to the superior longitudinal sinus, without evidence of previous bleeding or parenchymal ischemic lesion ( Figures 1A and 1B) .
During the patient's hospital stay, there was a favorable clinical and radiological evolution without neurological deterioration; therefore, the patient and doctors decided to continue pregnancy until fetal maturity. In this context, it was decided to postpone the diagnostic angiography and eventual embolization to postpartum period.
The patient then received regular follow-up with neurosurgery, obstetrics, and anesthesiology visits, presenting a stable condition without making use of any medicines. Although normal delivery was not contraindicated, the team proposed and discussed performing an elective cesarean section with the patient. On schedule, the patient was admitted for cesarean section, clinically asymptomatic from neurological and cardiovascular standpoints. In the delivery room, the team continuously monitored electrocardiographic tracing, pulse oximetry, invasive blood pressure, and respiratory rate, aside from assessing fetal well-being.
Cesarean section was performed under epidural anesthesia with titrated administration of 14 mL lidocaine (with epinephrine) at 20 mg.mL -1 and sufentanil at 1 microg.mL -1 with sensory block T6 . During the intraoperative period, there was an isolated episode of hypotension (MBP drop not exceeding 20% of baseline), reversed with two intravenous bolus of phenylephrine (50 mg), without other complications. An intensive care unit (ICU) stay was prescheduled but it was not necessary.
After delivery, the team guaranteed hemostasis by uterine massage and slow infusion of oxytocin (40U in 1000 mL of 5% dextrose in saline, at about 80 mL.h -1 ), without hemodynamic repercussion.
The male child was born weighing 3,230g with Apgar score of 10/10 at 1 and 5 minutes, respectively.
Postoperative analgesia was maintained with 1g of intravenous paracetamol every 6 hours and 3 epidural bolus of 10 mL ropivacaine (1.2 mg.mL -1 ) and morphine (0.2 mg.mL -1 ) every 12 hours (until 36 hours after cesarean section). For rescue analgesia, an epidural bolus of 6 mL ropivacaine (1.2 mg.mL -1 ) was prescribed whenever numerical pain scale > 4 (respecting intervals between administrations over 1 hour). Pain at rest was always under control; pain upon mobilization was controlled by using two rescue boluses: and another at 6 and one at 18 hours post-cesarean. The parturient recovered bowel and bladder function spontaneously within 24 hours, without nausea or vomiting, itching or motor blockade during epidural analgesia.
In the immediate postpartum period, there were no complications from the obstetric or anesthetic standpoint. There were no hemodynamic changes nor neurological decompensation manifestations.
The patient was discharged on the fourth day postpartum, clinically stable and referred to the interventional neuroradiology consultation.
Eight weeks after delivery, AVM embolization was performed under deep sedation with remifentanil infusion without complications. The patient was discharged clinically asymptomatic at the sixth day post-embolization. Currently, she maintains follow-up with neurosurgery.
Discussion
There are few case reports and studies of AVM management during pregnancy, particularly those evaluating intracranial hemorrhage (ICH) in this context 10, 11 . This is a controversial topic even today 1, 3, 4, 7, 8, 12 . In 1974, Robinson et al., 13 evaluating 24 cases, concluded that a woman who has had AVM would have 87% chance of developing ICH during pregnancy. On the other hand, Horton et al. 9 in 1990, in a study of 451 women of childbearing age with AVM, concluded that pregnancy does not increase the risk of bleeding of an AVM, estimating it at 3.5% (risk of bleeding in the non pregnant female population of childbearing age, with an AVM, estimated at 3.1%). On the other hand, the risk of re-bleeding at one year after the fi rst bleeding during pregnancy in women whose AVM was not intervened immediately after the event, appears to be increased to 6%, compared to the risk of re-bleeding in non-pregnant population 3, 9 . The therapeutic strategy in these situations is based on case-by-case weighted evaluation of the treatment risks versus the risk of bleeding during the remainder of pregnancy, if AVM is not treated. Risks to the fetus should also be considered during the intervention, either by embolization, surgical, or other techniques. Although the best strategy for management of symptomatic AVM during pregnancy is not yet defi ned, one can say that the postponement of angiography to the postpartum period has the obvious advantage of minimizing fetal exposure to radiation and contrast medium, aside from avoiding the signifi cant risk of complications during intervention 3, 12 . In most cases, the risk-benefi t analysis seems not to support the elective treatment of AVM during pregnancy 3 .
In what concerns the delivery, despite what had been previously reported 13 , there is no evidence that normal delivery is associated with an increased bleeding risk in pregnant women with intact AVM. Horton et al. believe that delivery in a patient with AVM, which was not surgically excised, can be performed either vaginally or by cesarean section 3,9,14. On the other hand, there are no studies comparing delivery modes in pregnant women with AVM rupture (ICH), but in the few cases reported the option was to perform cesarean sections 10, 14 . In the case described here, elective cesarean section was the option of the multidisciplinary team, considering not only the risk of re-bleeding, the control of timing and duration of delivery and hemodynamic stability during childbirth. Reservation of neonate and adults ICU vacancies were taken into account on the planning.
From a strictly anesthetic point of view in the absence of established guidelines, our primary goal was to maintain parturient cardiovascular stability 10 , avoiding hypotension, (which could compromise the uteroplacental vascularization), and hypertension, (which could increase the risk of bleeding). In this sense, we discuss two dichotomies: general anesthesia / neuraxial anesthesia and epidural anesthesia/ spinal anesthesia.
Although the technique of general anesthesia (GA) with opioids, propofol, and volatile anesthetics is described as safe in emergencies in these pregnant women 10 , neuraxial anesthesia has indisputable advantages over hemodynamic instability caused by endotracheal intubation and extubation, and avoids increased intracranial pressure associated with positive pressure ventilation and emesis associated with GA.
Comparing epidural and spinal block, in the fi rst, the more gradual onset of sympathetic blockade and existence of compensating phenomena seem to favor hemodynamic stability 15 . The local anesthetic and adrenalin absorption through the epidural space appears to have an effect with increased cardiovascular output and heart rate 16 . We chose to perform an epidural blockade with fractionated administration of lidocaine with epinephrine (20 mg.mL -1 ), with a total of 14 mL. We emphasize that the anesthetic option was discussed and defi ned together with the neurosurgeon. Lidocaine with epinephrine was the lo-cal anesthetic chosen since it is the most frequently in our institution. The available studies seem to show no benefi t of a local anesthetic over another 16 . The patient was monitored before anesthesia with invasive pressure for a more reliable control of hemodynamic changes. The episode of hypotension was rapidly and easily reversed with phenylephrine, a α 1 agonist; evidence shows that phenylephrine seems to be more appropriate for hypotension after regional anesthesia in pregnant women compared to other vasopressors 17 .
Conclusion
Patients with symptomatic AVM during pregnancy are challenging in terms of medical approach in general, and of anesthetic management in particular. There is no consensus regarding the optimal timing for AVM treatment or for delivery, as well as for the most appropriate delivery method and anesthesia technique. In the case described here, pregnancy seemed viable to the medical team involved. A 39-week pregnant woman had a close monitoring and the cesarean section was performed under continuous and invasive monitoring, with epidural anesthesia uneventfully. In this context, this seems to be a safe strategy for such cases.
